Drugs for Gastrointestinal Diseases — MCQs

Drugs for Gastrointestinal Diseases Indian Medical PG Practice Questions and MCQs

Question 61: Which of the following drugs commonly causes diarrhea as a side effect?

A. Morphine
B. Atropine
C. Lithium
D. Magnesium sulfate (Correct Answer)

Explanation: **Explanation:** **Magnesium sulfate** is the correct answer because it acts as an **osmotic laxative**. Magnesium salts are poorly absorbed in the gastrointestinal tract. Their presence in the intestinal lumen creates an osmotic gradient that draws water into the bowel, increasing intraluminal pressure and stimulating peristalsis. This mechanism is why magnesium-containing antacids and laxatives commonly cause **diarrhea** as a side effect. **Analysis of Incorrect Options:** * **Morphine:** As an opioid agonist, it acts on $\mu$-receptors in the myenteric plexus to decrease intestinal motility and increase sphincter tone. This leads to **constipation**, not diarrhea. * **Atropine:** This is a muscarinic antagonist (anticholinergic). By blocking parasympathetic stimulation of the gut, it reduces secretions and slows down GI motility, leading to **constipation** and dry mouth. * **Lithium:** While lithium can occasionally cause acute nausea or diarrhea during the initiation of therapy, its classic and most high-yield GI-related side effect in chronic use is not diarrhea, but rather its interference with ADH (causing nephrogenic diabetes insipidus). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Antacids:** **M**agnesium **M**akes stool **M**ove (Diarrhea); **A**luminum **A**lways **A**rrests stool (Constipation). * **Therapeutic Use:** Magnesium sulfate is the drug of choice for **Eclampsia** (seizures) and is also used in Torsades de Pointes. * **Contraindication:** Magnesium salts should be avoided in patients with **renal failure** due to the risk of hypermagnesemia (causing muscle weakness and respiratory depression).

Question 62: Aprepitant is used as:

A. Antidepressant
B. Antiemetic (Correct Answer)
C. Antihypertensive
D. Diuretic

Explanation: **Explanation:** **Aprepitant** is a selective, high-affinity antagonist at the **Substance P/Neurokinin-1 (NK1) receptors** located in the brainstem (area postrema and nucleus tractus solitarius). By blocking these receptors, it inhibits the emetic reflex triggered by Substance P. It is primarily used as an **antiemetic**, specifically for the prevention of both acute and delayed phases of **Chemotherapy-Induced Nausea and Vomiting (CINV)**, often in combination with 5-HT3 antagonists (like Ondansetron) and Dexamethasone. **Analysis of Incorrect Options:** * **A. Antidepressant:** While Substance P is involved in mood regulation, NK1 antagonists have not shown significant efficacy in treating clinical depression. Standard antidepressants include SSRIs, SNRIs, or TCAs. * **C. Antihypertensive:** Aprepitant has no effect on peripheral vascular resistance or cardiac output and is not used to lower blood pressure. * **D. Diuretic:** It does not influence renal electrolyte handling or water excretion. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** NK1 receptor antagonist (blocks Substance P). * **Fosaprepitant:** This is the water-soluble **prodrug** of Aprepitant, administered intravenously. * **Drug Interactions:** Aprepitant is a substrate, moderate inhibitor, and inducer of **CYP3A4**. It can increase levels of drugs like Dexamethasone (dose reduction required) and decrease the efficacy of Warfarin and oral contraceptives. * **Clinical Use:** It is the drug of choice for **delayed emesis** associated with highly emetogenic chemotherapy (e.g., Cisplatin).

Question 63: All of the following statements are true regarding ondansetron except?

A. It is the antiemetic of choice for chemotherapy-induced vomiting.
B. It is a 5-HT3 receptor antagonist.
C. It has significant drug interactions. (Correct Answer)
D. It may possess 5-HT4 agonism.

Explanation: ### Explanation **Ondansetron** is a prototype 5-HT3 receptor antagonist widely used in clinical practice. **Why Option C is the correct answer (The False Statement):** Ondansetron is known for its **excellent safety profile** and **minimal drug-drug interactions**. It is metabolized by the hepatic cytochrome P450 system (CYP3A4, CYP2D6, and CYP1A2), but it does not significantly inhibit or induce these enzymes. Unlike many other drugs used in oncology or GI medicine, it rarely requires dose adjustments when co-administered with other medications, making it a preferred choice in multi-drug regimens. **Analysis of Incorrect Options:** * **Option A:** It remains the **first-line drug (DOC)** for preventing and treating chemotherapy-induced nausea and vomiting (CINV), as well as radiotherapy-induced and postoperative vomiting. * **Option B:** Its primary mechanism is the **competitive blockade of 5-HT3 receptors** located both peripherally (on vagal afferents in the GI tract) and centrally (in the Chemoreceptor Trigger Zone/CTZ). * **Option D:** While primarily a 5-HT3 antagonist, some studies suggest ondansetron may possess weak **5-HT4 agonism**, which might contribute to its effects on GI motility, though this is not its main clinical mechanism. **High-Yield NEET-PG Pearls:** * **Side Effects:** The most common side effects are **headache** and **constipation**. * **ECG Changes:** A critical high-yield fact is that ondansetron can cause **QT interval prolongation**; caution is required in patients with electrolyte imbalances or congenital long QT syndrome. * **Site of Action:** It acts at both the **CTZ** (Central) and the **STN/Vagal nerve endings** (Peripheral). * **Ineffectiveness:** It is **not effective** in Motion Sickness (where H1 and M1 blockers are used).

Question 64: All of the following drugs intensify gastrointestinal motility except?

A. Papaverine (Correct Answer)
B. Metoclopramide
C. Domperidone
D. Cisapride

Explanation: ### Explanation The question asks to identify the drug that does **not** intensify gastrointestinal (GI) motility. To answer this, we must distinguish between **prokinetic agents** (which increase motility) and **antispasmodics** (which decrease motility). **1. Why Papaverine is the Correct Answer:** Papaverine is a **non-specific phosphodiesterase (PDE) inhibitor** and a direct-acting smooth muscle relaxant. By increasing intracellular cAMP and inhibiting calcium channels, it causes relaxation of the GI smooth muscle. Therefore, it **decreases** GI motility and is used clinically as an antispasmodic to treat colicky pain. It does not intensify motility. **2. Why the Other Options are Incorrect:** * **Metoclopramide (Option B):** A potent prokinetic. It acts as a **D2 receptor antagonist** and a **5-HT4 agonist**, which increases the release of Acetylcholine (ACh) at the myenteric plexus, thereby intensifying GI motility and increasing Lower Esophageal Sphincter (LES) tone. * **Domperidone (Option C):** A peripheral **D2 receptor antagonist**. Like metoclopramide, it blocks the inhibitory effect of dopamine on ACh release in the gut, leading to increased gastric emptying and peristalsis. * **Cisapride (Option D):** A selective **5-HT4 receptor agonist**. It enhances ACh release from the myenteric plexus throughout the GI tract, making it a strong prokinetic agent. **High-Yield Clinical Pearls for NEET-PG:** * **Prokinetic Mechanism:** Most prokinetics work by increasing **Acetylcholine** release. * **Metoclopramide Side Effects:** Can cause **Extrapyramidal Symptoms (EPS)** because it crosses the Blood-Brain Barrier (BBB). Domperidone has a lower risk of EPS as it does not cross the BBB. * **Cisapride Caution:** It is known to cause **QT interval prolongation** (Torsades de Pointes) due to its action on cardiac K+ channels. * **Specific PDE Inhibitor:** While Papaverine is non-specific, **Drotaverine** is a selective PDE-4 inhibitor frequently used for intestinal and biliary colic.

Question 65: Why is glucose added to oral rehydration solution (ORS)?

A. To improve the palatability of the solution.
B. To enhance the absorption of sodium and water. (Correct Answer)
C. To increase the shelf life of the solution.
D. To improve the taste of the solution.

Explanation: **Explanation:** The addition of glucose to Oral Rehydration Solution (ORS) is based on the physiological principle of **Sodium-Glucose Cotransport**. In the luminal membrane of the small intestine, the **SGLT-1 (Sodium-Glucose Linked Transporter)** protein facilitates the coupled transport of one molecule of glucose with two ions of sodium. As sodium is actively transported into the enterocytes, it creates an osmotic gradient that pulls water along with it (solvent drag). Crucially, this transport mechanism remains intact even during secretory diarrheas like Cholera. Therefore, glucose is not added as a nutrient, but as a functional vehicle to drive the absorption of salt and water. **Analysis of Options:** * **Option B (Correct):** Glucose is the essential substrate required to activate the SGLT-1 transporter, ensuring rehydration. * **Options A & D (Incorrect):** While glucose may slightly improve the taste, this is a secondary benefit. In fact, excessive glucose (hyperosmolar ORS) can worsen diarrhea by causing osmotic water loss into the gut lumen. * **Option C (Incorrect):** Glucose does not act as a preservative; it can actually promote bacterial growth if the solution is contaminated. **High-Yield Clinical Pearls for NEET-PG:** * **WHO Reduced Osmolarity ORS:** The current standard has a total osmolarity of **245 mOsm/L** (Sodium: 75 mmol/L, Glucose: 75 mmol/L). This reduces the need for IV fluids and decreases stool output compared to the older 311 mOsm/L formula. * **Trisodium Citrate:** Added to ORS to correct metabolic acidosis and increase the shelf life (replacing Sodium Bicarbonate). * **Zinc Supplementation:** Recommended alongside ORS (20 mg/day for 14 days) to reduce the duration and severity of diarrhea.

Question 66: What is the drug of choice for cisplatin-induced emesis?

A. Metoclopramide
B. Domperidone
C. Ondansetron (Correct Answer)
D. Octreotide

Explanation: **Explanation:** **Correct Answer: C. Ondansetron** Cisplatin is a highly emetogenic chemotherapy agent. It causes nausea and vomiting by damaging enterochromaffin cells in the gastrointestinal tract, leading to a massive release of **serotonin (5-HT)**. This serotonin stimulates **5-HT₃ receptors** on vagal afferents and in the Chemoreceptor Trigger Zone (CTZ). **Ondansetron**, a selective 5-HT₃ receptor antagonist, effectively blocks these receptors, making it the first-line drug of choice for preventing acute chemotherapy-induced nausea and vomiting (CINV). **Analysis of Incorrect Options:** * **A. Metoclopramide:** A D₂ receptor antagonist with prokinetic properties. While used for mild emesis or gastroparesis, it is less effective than 5-HT₃ antagonists for highly emetogenic drugs like cisplatin and carries a risk of extrapyramidal side effects. * **B. Domperidone:** A peripheral D₂ antagonist. It is primarily used for drug-induced nausea (e.g., Levodopa) or GERD but is ineffective against the potent serotonin surge caused by cisplatin. * **C. Octreotide:** A somatostatin analogue used for secretory diarrhea (carcinoid syndrome) or variceal bleeding; it has no role in managing CINV. **NEET-PG High-Yield Pearls:** * **Combination Therapy:** For highly emetogenic chemotherapy (HEC), the current gold standard is a "Triple Regimen": **5-HT₃ Antagonist + Dexamethasone + NK₁ Receptor Antagonist** (e.g., Aprepitant). * **Side Effects:** The most common side effects of Ondansetron are **headache**, constipation, and **QT interval prolongation**. * **Delayed Emesis:** While Ondansetron is excellent for *acute* emesis (first 24 hours), **Aprepitant** is superior for *delayed* emesis (after 24 hours).

Question 67: Which of the following is NOT an effect of ranitidine when compared to cimetidine?

A. Action on H2 receptors
B. Given orally
C. Used with proton pump inhibitors
D. Anti-androgenic action (Correct Answer)

Explanation: **Explanation:** The question asks to identify which effect is **not** associated with ranitidine when compared to cimetidine. Both drugs are H2-receptor antagonists (H2RAs), but they differ significantly in their side-effect profiles and potency. **1. Why "Anti-androgenic action" is the correct answer:** Cimetidine is notorious for its **anti-androgenic effects**. It binds to androgen receptors and inhibits the metabolism of estradiol, leading to clinical conditions such as **gynecomastia** in men and galactorrhea in women. **Ranitidine**, along with newer H2RAs like famotidine, lacks these anti-androgenic properties. Therefore, ranitidine does not cause these hormonal side effects. **2. Analysis of Incorrect Options:** * **A. Action on H2 receptors:** Both drugs share the same primary mechanism of action—competitive inhibition of histamine at H2 receptors on gastric parietal cells to reduce acid secretion. * **B. Given orally:** Both cimetidine and ranitidine have good oral bioavailability and are commonly administered via the oral route. * **C. Used with proton pump inhibitors:** While not a standard first-line combination (as PPIs are superior), both can theoretically be used in specific refractory cases or "nocturnal acid breakthrough" scenarios, though this is a shared clinical context rather than a differentiating side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Inhibition:** Cimetidine is a potent **P450 enzyme inhibitor**, leading to numerous drug interactions (e.g., increasing levels of warfarin, phenytoin, and theophylline). Ranitidine has negligible effects on hepatic enzymes. * **Potency:** Ranitidine is 5–10 times more potent than cimetidine. * **Blood-Brain Barrier:** Cimetidine can cross the BBB, occasionally causing confusion or hallucinations in elderly patients; ranitidine has much lower CNS penetration.

Question 68: What is true about the proton-pump inhibitor omeprazole?

A. Does not bind to plasma protein.
B. CYP2C19 predicts efficacy. (Correct Answer)
C. Oral bioavailability is 80%.
D. All of the above.

Explanation: **Explanation:**1. Why Option B is Correct:Omeprazole is primarily metabolized in the liver by the cytochrome P450 enzyme **CYP2C19**. Genetic polymorphisms in this enzyme significantly influence the drug's pharmacokinetics. Patients who are "poor metabolizers" (common in Asian populations) have higher plasma concentrations and better acid suppression, whereas "rapid metabolizers" may experience therapeutic failure. Therefore, the CYP2C19 genotype is a major predictor of the drug's clinical efficacy and duration of action [3].2. Why Other Options are Incorrect:* **Option A:** Omeprazole is **highly protein-bound** (approximately 95%), mainly to albumin. This is a common characteristic of most proton pump inhibitors (PPIs).* **Option C:** The oral bioavailability of omeprazole is relatively low, around **35–40%** [1], due to its instability in gastric acid (requiring enteric coating) [2] and significant first-pass metabolism. In contrast, drugs like Lansoprazole or Pantoprazole have higher bioavailability (80% or more).* **Option D:** Since A and C are incorrect, "All of the above" is false.**High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Irreversible inhibition of the **H+/K+ ATPase pump** (the "final common pathway" of acid secretion) [2].* **Activation:** Omeprazole is a **prodrug** that requires an acidic environment (pH < 2) in the canaliculi of parietal cells to be converted into its active form (sulfenamide) [1, 2].* **Administration:** Should be taken **30–60 minutes before a meal** (usually breakfast) to ensure peak plasma levels coincide with the maximal activation of proton pumps.* **Drug Interaction:** Omeprazole inhibits CYP2C19, which can **decrease the activation of Clopidogrel** (a prodrug), potentially increasing the risk of cardiovascular events. Pantoprazole is the preferred PPI when using Clopidogrel.

Question 69: What is the drug of choice for intractable hiccups?

A. Metoclopramide
B. Haloperidol
C. Thioridazine
D. Chlorpromazine (Correct Answer)

Explanation: **Chlorpromazine** is the only FDA-approved medication specifically indicated for the treatment of intractable hiccups (singultus). Intractable hiccups are defined as those lasting more than one month. **Why Chlorpromazine is the Correct Choice:** The pathophysiology of hiccups involves a reflex arc consisting of the vagus nerve, phrenic nerve, and sympathetic chain (T6–T12), coordinated by a "hiccup center" in the brainstem. Chlorpromazine, a typical antipsychotic of the low-potency phenothiazine class, acts as a potent **dopamine (D2) receptor antagonist** in the hypothalamus and brainstem. It effectively interrupts the hiccup reflex arc through its central sedative and antagonistic effects. **Analysis of Incorrect Options:** * **Metoclopramide (A):** While it is a prokinetic and D2 antagonist used as a second-line agent (especially if the cause is gastric stasis), it is not the primary drug of choice. * **Haloperidol (B):** This is a high-potency antipsychotic that has been used off-label for hiccups, but it lacks the formal approval and historical clinical preference established for Chlorpromazine. * **Thioridazine (C):** Although it is a phenothiazine like chlorpromazine, it is not used for hiccups due to its significant side-effect profile, including the risk of QTc prolongation. **High-Yield Clinical Pearls for NEET-PG:** * **First-line for Intractable Hiccups:** Chlorpromazine (Oral or IV). * **Alternative/Second-line agents:** Baclofen (GABA-B agonist), Gabapentin, or Metoclopramide. * **Non-pharmacological trigger:** Gastric distension is the most common trigger for acute hiccups. * **Side effect to watch:** When using Chlorpromazine, monitor for hypotension and extrapyramidal symptoms (EPS).

Question 70: Which drug is effective in ulcerative colitis?

A. 5-aminosalicylic acid (5-ASA) (Correct Answer)
B. Corticosteroids
C. Sulfasalazine
D. Antibiotics

Explanation: **Explanation:** The management of Ulcerative Colitis (UC) primarily targets the reduction of mucosal inflammation. **5-aminosalicylic acid (5-ASA)**, also known as Mesalamine, is considered the first-line drug for inducing and maintaining remission in mild-to-moderate UC. It acts locally on the colonic mucosa by inhibiting cyclooxygenase (COX) and lipoxygenase (LOX) pathways, thereby reducing the production of pro-inflammatory prostaglandins and leukotrienes. **Analysis of Options:** * **5-ASA (Option A):** This is the most accurate answer because it represents the active therapeutic moiety. Modern formulations (e.g., pH-sensitive granules or delayed-release tablets) deliver the drug directly to the colon, minimizing systemic absorption and side effects. * **Sulfasalazine (Option C):** While effective, Sulfasalazine is a prodrug consisting of 5-ASA linked to **Sulfapyridine**. The sulfapyridine component is responsible for most of the drug's toxicity (hypersensitivity, bone marrow suppression). Therefore, pure 5-ASA is preferred. * **Corticosteroids (Option B):** These are highly effective for inducing remission in acute flares but are **never** used for maintenance therapy due to significant long-term systemic side effects. * **Antibiotics (Option D):** Unlike in Crohn’s disease (where Metronidazole or Ciprofloxacin may be used for perianal disease), antibiotics have no proven primary role in the routine management of UC unless a secondary infection is suspected. **NEET-PG High-Yield Pearls:** * **Site of Action:** 5-ASA works topically on the luminal surface; it is not a systemic immunosuppressant. * **Sulfasalazine Side Effects:** Can cause reversible **oligospermia** in males (5-ASA does not). * **Drug of Choice (DOC):** 5-ASA is the DOC for maintenance; Corticosteroids are the DOC for acute severe attacks. * **Mechanism:** Inhibition of NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is also a proposed mechanism for 5-ASA.

Practice by Chapter

Acid-Peptic Disease Therapeutics

Practice Questions

Proton Pump Inhibitors

Practice Questions

H2 Receptor Antagonists

Practice Questions

Antacids and Mucosal Protectants

Practice Questions

Antiemetics

Practice Questions

Prokinetic Agents

Practice Questions

Laxatives and Purging Agents

Practice Questions

Antidiarrheal Drugs

Practice Questions

Drugs for Inflammatory Bowel Disease

Practice Questions

Pancreatic Enzyme Supplements

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free